These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17570555)

  • 1. Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
    Herrema H; Smit GP; Reijngoud DJ; Kuipers F
    J Hepatol; 2007 Aug; 47(2):298-300; author reply 300-1. PubMed ID: 17570555
    [No Abstract]   [Full Text] [Related]  

  • 2. Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group.
    Haagsma EB; Smit GP; Niezen-Koning KE; Gouw AS; Meerman L; Slooff MJ
    Hepatology; 1997 Mar; 25(3):537-40. PubMed ID: 9049194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type III glycogen storage disease associated with hepatocellular carcinoma].
    Cosme A; Montalvo I; Sánchez J; Ojeda E; Torrado J; Zapata E; Bujanda L; Gutiérrez A; Arenas I
    Gastroenterol Hepatol; 2005 Dec; 28(10):622-5. PubMed ID: 16373012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?
    Demo E; Frush D; Gottfried M; Koepke J; Boney A; Bali D; Chen YT; Kishnani PS
    J Hepatol; 2007 Mar; 46(3):492-8. PubMed ID: 17196294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natural course and progression of liver cirhosis in patients with hepatitis C].
    Franke A; Zeuzem S
    Z Gastroenterol; 1998 Jun; 36(6):539-41. PubMed ID: 9675840
    [No Abstract]   [Full Text] [Related]  

  • 6. [The progression of type B liver cirrhosis and the occurrence of hepatocellular carcinoma].
    Higashi T; Urabe Y; Nouso K; Tsuji T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):660-6. PubMed ID: 12442464
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatty-acid metabolism and the pathogenesis of hepatocellular carcinoma: review and hypothesis.
    Ockner RK; Kaikaus RM; Bass NM
    Hepatology; 1993 Sep; 18(3):669-76. PubMed ID: 8395460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease.
    Siciliano M; De Candia E; Ballarin S; Vecchio FM; Servidei S; Annese R; Landolfi R; Rossi L
    J Clin Gastroenterol; 2000 Jul; 31(1):80-2. PubMed ID: 10914784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the incidence of intrahepatic multicentric recurrence of hepatocellular carcinoma more frequent in "the carcinogenic stage" than in liver cirrhosis?
    Izumi N
    J Gastroenterol; 2003; 38(9):918-20. PubMed ID: 14564643
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular Adenomas and Carcinoma in Asymptomatic, Non-Cirrhotic Type III Glycogen Storage Disease.
    Oterdoom LH; Verweij KE; Biermann K; Langeveld M; van Buuren HR
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):515-8. PubMed ID: 26697579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma and NASH.
    Kudo M
    J Gastroenterol; 2004; 39(4):409-11. PubMed ID: 15168260
    [No Abstract]   [Full Text] [Related]  

  • 12. [A case of Biermer's anemia with liver cirrhosis (development followed for 14 years, death due to hepatocarcinoma)].
    Olmer J; Moutaffian JJ
    Mars Med; 1969; 106(4):345-8. PubMed ID: 4315575
    [No Abstract]   [Full Text] [Related]  

  • 13. [A report on an adult case of type III glycogenosis with primary liver cancer and liver cirrhosis].
    Shimizu J; Shiraishi H; Sakurabayashi S; Sugiura F; Takizawa H; Miyazaki K; Matsumoto Y; Nishizato Y; Sato T; Watanabe Y; Masuda S; Watanbe Y; Otaka Y; Sakiyama T; Kitagawa T; Mizuguchi S; Ashizawa S
    Nihon Shokakibyo Gakkai Zasshi; 1982 Dec; 79(12):2328-32. PubMed ID: 6300490
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver cirrhosis in metabolic disorders].
    Tazawa Y
    Nihon Rinsho; 1994 Jan; 52(1):223-8. PubMed ID: 8114297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Obesity and its association with cryptogenic cirrhosis and hepatocarcinoma].
    Lizardi-Cervera J; Motola-Kuba D; Guevara-González L
    Gac Med Mex; 2004; 140 Suppl 2():S77-83. PubMed ID: 15641476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective analysis of risk factors for hepatocellular carcinoma on patients with cirrhosis.
    Di Costanzo GG
    Hepatology; 2003 Oct; 38(4):1061; author reply 1061. PubMed ID: 14512897
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatocellular carcinoma in cirrhosis. The surgeon's point of view].
    Smadja C; Franco D
    Ann Gastroenterol Hepatol (Paris); 1989; 25(4):129-31. PubMed ID: 2548431
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatocellular adenoma in glycogen storage disease type IV.
    Alshak NS; Cocjin J; Podesta L; van de Velde R; Makowka L; Rosenthal P; Geller SA
    Arch Pathol Lab Med; 1994 Jan; 118(1):88-91. PubMed ID: 8285839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global impact of hepatic fibrosis and end-stage liver disease.
    Lim YS; Kim WR
    Clin Liver Dis; 2008 Nov; 12(4):733-46, vii. PubMed ID: 18984463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
    Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
    J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.